Interferon Treatments: How to Use an Endogenous System as a Therapeutic Agent
- 1 May 1992
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Interferon Research
- Vol. 1992 (special_) , 109-118
- https://doi.org/10.1089/jir.1992.1992.109
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- Molecular cloning and expression of the human interferon-γ receptorCell, 1988
- Effect of Recombinant Interferon-γ on Protein Content, Phagocytic, and Cytotoxic Activity of Mouse Peritoneal MacrophagesJournal of Interferon Research, 1988
- Internalization and Transport of Mouse Beta-Interferon into the Cell NucleusJournal of Interferon Research, 1986
- An Animal Model System for Investigating the AntiTumor Effects of Human InterferonJournal of Interferon Research, 1983
- Interferon action: Effects of mouse α and β interferons on rosette formation, phagocytosis, and surface-antigen expression of cells of the macrophage-type line RAW 309Cr.1Cellular Immunology, 1982
- Interferon inhibits melanogenesis in b-16 mouse melanoma cellsBiochemical and Biophysical Research Communications, 1981
- Common pathways of interferon and hormonal actionNature, 1980
- Immune and virus-induced interferons may activate cells by different derepressional mechanismsNature, 1980
- Repression of Interferon Action: Induced Dedifferentiation of Embryonic CellsScience, 1971